Ngm Biopharmaceuticals Inc

-0.02 (-1.28%)
6:05:00 PM EDT: $1.55 +0.01 (+0.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)NA
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.22 Million
Adjusted EPS-$0.35
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Ngm Biopharmaceuticals Inc Stock, :NGM

333 Oyster Point Boulevard, South San Francisco, California 94080-7014
United States of America
Phone: +1.650.243.5555
Number of Employees: 138


NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum. The company was founded by Jin Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.